Government of Canada invested $27 million in Coronavirus research
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
Innovation Pharma signs second MTA to explore Brilacidin as Coronavirus COVID-19 treatment
On Mar. 6, 2020, Innovation Pharma announced that a second MTA has been signed to ship Brilacidin to…
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
Heat Biologics collaborated with University of Miami to develop COVID-19 Coronavirus vaccine
On Mar. 5, 2020, Heat Biologics announced a strategic collaboration with the University of Miami Miller School of…
Biotechnology | CDC | COVID-19 | Diagnostics
Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
LabCorp launched test for Coronavirus (COVID-19)
On Mar. 5, 2020, LabCorp announced that it was making its LabCorp 2019 Novel Coronavirus (COVID-19), NAA test…
OPKO Health introduced Coronavirus disease (COVID-19) test
On Mar. 5, 2020, BioReference Laboratories, an OPKO Health company, announced it was offering a test for the…
German lab demonstrated feasibility to detect SARS-Coronavirus-2 using Hologic’s Panther Fusion System
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…
University of Washington Medicine deployed new test for coronavirus
On Mar. 4, 2020, the UW Medicine Clinical Virology Lab announced it had received U.S. Food and Drug…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
Heat Biologics launched program to develop vaccine to protect against COVID-19 coronavirus
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
Biotechnology | COVID-19 | FDA | Therapeutics
Mateon updated Rapid Antiviral Response Program Initially targeting COVID-19
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…
Innovation Pharma provided scientific rationale and clinical development perspectives for Brilacidin as potential Coronavirus treatment
On Mar. 2, 2020, Innovation Pharma provided the scientific rationale and clinical development perspectives for Brilacidin, the Company’s…
COVID-19 | Diagnostics | Therapeutics | WHO
UN released $15 million to help vulnerable countries battle the spread of the coronavirus
On Mar. 1, 2020, the United Nations Humanitarian Chief Mark Lowcock released US$15 million from the Central Emergency…
University of Washington Medicine received FDA permission to conduct coronavirus tests
On Feb. 29, 2020, the University of Washington (UW) Medicine Clinical Virology Lab announced it had received U.S….
Mutations can reveal how the coronavirus moves, but they’re easy to overinterpret
On Feb. 28, 2020, immediately after Christian Drosten published a genetic sequence of the novel coronavirus online, he…
CDC | COVID-19 | Diagnostics | NIH | Therapeutics | Vaccine
COVID-19 a reminder of the challenge of emerging infectious diseases
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
Altimmune Completed First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
New images of novel Coronavirus SARS-CoV-2 made available
On Feb. 26, 2020, the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories (NIAID-RML) announced it…
Tonix Pharma announced collaboration with Southern Research to develop vaccine to protect against COVID-19 based on Horsepox virus
On Feb. 26, 2020, Tonix Pharmaceuticals announced a strategic collaboration with Southern Research to support the development of…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
NIH clinical trial of remdesivir to treat COVID-19 began for adults with coronavirus disease
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
Clover and GSK announced research collaboration to evaluate Coronavirus vaccine candidate with pandemic adjuvant system
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
Innovation Pharma submited Material Transfer Agreement to study defensin mimetic Brilacidin for Coronavirus
On Feb. 24, 2020, Innovation Pharmaannounced the Company submitted a Material Transfer Agreement (MTA) with a leading U.S.-based…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…